On July 26, 2011, at Faculty of Tropical Medicine, Mahidol University, Clin. Prof. Piyasakol Sakolsatayadorn, President of Mahidol University presided over the opening ceremony of the Center of Excellence for Antibody Research (CEAR), Mahidol Osaka Center for Infectious Disease (MOCID), Mahidol-JST-JICA Friendship Laboratory and BIKEN Endowed Department of Dengue Vaccine Development.

        In this occasion, Dr. Pongrama Ramasoota, Director of CEAR, Prof. Dr. Kazuyoshi Ikuta, Chief Advisor of JST-JICA and Assoc. Prof. Eiji Konishi, Kobe University Graduate School of Health Science made a speech for introduction this program.

         Faculty of Tropical Medicine, Mahidol University (FTM-MU) has promote and increase the discovery research in the brand-new Center of Excellence for Antibody Research (CEAR), was launched in late 2009. Simultaneously, CEAR, FTM-MU and Research Institute of Microbial Diseases (RIMD), Osaka University (OU), have started the research collaboration project “Research and Development of Therapeutic Products against Infectious Diseases, Especially Dengue virus Infection” and set up “MAHIDOL-JST-JICA friendship Laboratory” with partial support of 46 million baht (equipment, and reagents), from the Japanese government, by 4 years (2009-2012) contracted under the “Science and Technology Research Partnership for Sustainable Development” promoted by Japan International Cooperation Agency (JICA) and also technical support by experts from RIMD, OU. Until present (May, 2011), 11 human monoclonal antibodies (MABs) clones that can neutralize 4 serotypes of Dengue virus have been developed, which are waiting for patent application. These 11 MABs are candidate for Dengue treatment in the future.
       

Post Date : July 27, 2011